Unknown

Dataset Information

Risks of trastuzumab-related cardiotoxicity in breast cancer patients in Taiwan.


ABSTRACT:

Aims

In contrast to Western patients with breast cancer, Asian patients are relatively younger at diagnosis, and most are free from traditional cardiovascular risk factors. Despite trastuzumab-related major adverse cardiac and cerebrovascular event (MACCE) being reported, its incidence and predictors remain unknown in Taiwan.

Methods and results

Through a three-hospital retrospective cohort study, we analysed the incidence of MACCE in 386 breast cancer patients' exposure to trastuzumab from 2010 to 2018. To further reconfirm our findings, in a nationwide study using the Taiwanese National Health Insurance Research Database and National Cancer Registry, we identified 13 502 women diagnosed with breast cancer who received chemotherapy from 2010 to 2015 and found 6751 women who

SUBMITTER: Chang WT 

PROVIDER: S-EPMC8712795 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature